Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia 2Hematologic Neoplasms 2Vomiting 1Stomatitis 1Pain 1Neoplasm, Residual 1Nausea 1Lymphoma 1Fatigue 1Brain Neoplasms 1Attention Deficit Disorder with Hyperactivity 1Anxiety Disorders 1

Interventions

Methylphenidate 2Methods 2sargramostim 1ropidoxuridine 1entrectinib 1entinostat 1cc-486 1carboxyamido-triazole 1bintrafusp alfa protein, human 1Watchful Waiting 1WP 744 1Vincristine 1Thalidomide 1Temozolomide 1Ritonavir 1Radiotherapy 1Quality of Life 1Psychology, Positive 1Psychiatric Rehabilitation 1Pemetrexed 1Patient Reported Outcome Measures 1Paclitaxel 1Observation 1O(6)-benzylguanine 1N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide 1Molecular Diagnostic Techniques 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Control Groups × Other hematologic neoplasm × Clear all
NCT00498719 2020-12-31

Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer

M.D. Anderson Cancer Center

Unknown
30 enrolled
CNSLymphoidOther hematologic neoplasm

Attention Deficit Disorder with Hyperactivity, Brain Neoplasms, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡